Then, we examined NEK2 expression along with clinicopathological characteristics in the TCGA-KIRC cohort to ascertain the effects of different NEK2 expression levels on ccRCC patients. The gene discussed is NEK2; the disease is nonpapillary renal cell carcinoma.